Paula Chu

Paula Chu is an accomplished professional in Outcomes Research, currently serving as Director at Organon since November 2021. Prior to this role, Paula was the HTA Evidence Lead for Global Product Strategy at Roche from June 2016 to October 2021, where responsibilities included the development and management of comparative efficacy evidence for payer submissions and internal brand strategies, as well as overseeing comprehensive evidence packages comprising systematic reviews and indirect treatment comparisons. Paula holds a Doctor of Philosophy (Ph.D.) in Health Policy & Decision Science from Harvard University, earned between 2010 and 2016, a Master's Degree in Global Health and Population from Harvard T.H. Chan School of Public Health (2007-2009), and a Bachelor's Degree in Biology/Biological Sciences from the University of Chicago (2001-2005).